rs886041246
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001032221.6(STXBP1):c.1217G>A(p.Arg406His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R406C) has been classified as Pathogenic.
Frequency
Consequence
NM_001032221.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373302.8 | c.1217G>A | p.Arg406His | missense_variant | Exon 14 of 20 | 1 | NM_003165.6 | ENSP00000362399.3 | ||
STXBP1 | ENST00000373299.5 | c.1217G>A | p.Arg406His | missense_variant | Exon 14 of 19 | 1 | NM_001032221.6 | ENSP00000362396.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 4 Pathogenic:8Other:2
- -
- -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.94 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.96 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change and different missense changes at the same codon (p.Arg406Cys, p.Arg406Gly, p.Arg406Leu / ClinVar ID: VCV000207431, VCV000419223, VCV000812768 / PMID: 26648591, 32581362) have been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000279904 /PMID: 20887364). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
ACMG evidence PS2, PM2, PP2, PP3, PP5 -
Variant interpreted as Pathogenic and reported on 04-16-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
- -
The missense variant c.1217G>A p.Arg406His in STXBP1 gene has been reported in heterozygous state in multiple individuals with early-onset epileptic encephalopathy Benson KA, et al., 2020, Zhu B, et al., 2020. Experimental studies show that STXBP1 protein levels of this variant is reduced to 20-30% of wild-type, suggesting the variant results in STXBP1 protein instability Zhu B, et al., 2020. The variant is novel not in any individuals in gnomAD Exomes and 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic/Likely Pathogenic. The amino acid Arginine at position 406 is changed to a Histidine changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by SIFT. The amino acid change p.Arg406His in STXBP1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:5
- -
Published functional studies in humanized Caenorhabditis elegans demonstrate significantly reduced and irregular pharyngeal pumping (an indicator of neuromuscular synaptic transmission), and STXBP1 protein levels reduced to 20-30% of wild-type, suggesting the variant results in STXBP1 protein instability (PMID: 32112430); Missense variants in this gene are often considered pathogenic (HGMD); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26865513, 24189369, 21762454, 32238909, 28191889, 33332765, 30266908, McCormick2021[BioRxiv], 29929108, 29896790, 34120799, 35007884, 25714420, 23934111, 26648591, 29191246, 29186148, 30842224, 33004838, 35851549, 31440721, 36482122, 33057194, 35982159, 20887364, 27171548, 32112430) -
- -
- -
STXBP1: PS2:Very Strong, PM2, PM5, PP2, PP3 -
Inborn genetic diseases Pathogenic:1
- -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 406 of the STXBP1 protein (p.Arg406His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early-onset epileptic encephalopathy (PMID: 20887364, 21762454, 23934111, 25714420, 26514728). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 279904). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt STXBP1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Infantile epilepsy syndrome Pathogenic:1
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-06-22 and interpreted as Pathogenic. The reporting laboratory might also submit to ClinVar. This variant was identified in multiple probands enrolled in Simons Searchlight. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at